Self-reported psychopathology among young, low-income, female ecstasy users.
This study examined the association of ecstasy (methylenedioxy-methylamphethamine) use with psychopathology among young, low-income females who sought care at university family planning clinics in Texas between December 2001 and May 2003. Participants reported drug use history and eight problem behavior syndromes by using the Young Adult Self-Report. The prevalence of ecstasy use was approximately 15%. About 90% of ecstasy users reported having used other drugs. Overall, ecstasy users were more likely to have exhibited delinquent behaviors and thought problems than exclusive marijuana users. Ecstasy users who continued to use any illicit drugs showed the most severe psychopathology. These findings indicate that elevated rates of self-reported psychopathology among ecstasy users may be partly attributable to the use of multiple drugs. Furthermore, it will also be important for future studies to assess the extent to which delinquent behaviors and thought problems mediate the transition of marijuana use to ecstasy use.
Wu
Z Helen
ZH
Department of Obstetrics & Gynecologyand, Center for Interdisciplinary Research in Women's Health. zhwu@utmb.edu
Baillargeon
Jacques G
JG
Berenson
Abbey B
AB
Holzer
Charles E
CE
D000046:Academic Medical Centers; D000293:Adolescent; D000328:Adult; D000554:Ambulatory Care Facilities; D000704:Analysis of Variance; D003430:Cross-Sectional Studies; D017831:Diagnosis, Dual (Psychiatry); D005260:Female; D006213:Hallucinogens; D006801:Humans; D013287:Illicit Drugs; D007604:Juvenile Delinquency / Q000523:psychology*; D001523:Mental Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000523:psychology; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D011203:Poverty; D015995:Prevalence; D011599:Psychopathology; D012647:Self-Assessment; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000523:psychology*; D013781:Texas / Q000453:epidemiology; D055815:Young Adult
D006213:Hallucinogens; D013287:Illicit Drugs; D018817:N-Methyl-3,4-methylenedioxyamphetamine